| INTRODUCTION
Coronary angiography (CA) is a fundamental diagnostic tool in patients with ischemic heart disease. However, visual assessment of lesion severity does not always predict hemodynamic significance of coronary artery stenosis, especially if subcritical (<75%). [1] [2] [3] [4] Fractional flow reserve (FFR) is the ratio between coronary pressures measured distally and proximally to the stenosis during maximal hyperemia, induced by administration of a vasodilator agent (usually adenosine). 5 Several randomized clinical trials (RCTs) have validated its utility in deferring invasive treatment of functionally nonsignificant lesions compared with visual angiographic assessment J Interv Cardiol. 2018;31:725-730. wileyonlinelibrary.com/journal/joic alone [6] [7] [8] [9] [10] and since more than 10 years FFR has been used to guide coronary revascularization.
The need of vasodilators to assess stenosis severity has been questioned, especially for patients with impairment of microcirculation -as those presenting with ACS (acute coronary syndromes) or with renal disease. 11, 12 Second, their use is associated with a not negligible risk of adverse effects. 13 Instantaneous wave-free ratio (iFR) is a recently developed physiological index used to assess the severity of stenosis. As opposed to FFR, iFR provides lesion assessment without the need to administer a vasodilator agent. It represents the pressure gradient across a coronary stenosis during the period of diastole in which microvascular resistance is low and stable (wave-free period). 14 iFR has been demonstrated non-inferior to FFR in guiding revascularization in two large RCTs. 15, 16 However, no study has compared efficacy and safety of iFR-guided versus CAguided strategy.
To address this issue, we performed a network meta-analysis of RCT and propensity score adjusted studies, confronting iFR and CA to FFR to drive revascularization.
| METHODS
The present study was performed according to the Cochrane Collaboration and the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statements.
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| Search
We searched for randomized trials in The Cochrane Collaboration
Central Register of Controlled Trials, EMBASE, and MEDLINE/ Pubmed. We restricted our searches to human studies, clinical trials, controlled trials, randomized trials, or studies with propensity score with matching. We used the keywords and Medical Subject Headings "percutaneous coronary intervention," "coronary angiography," "ffr,"
or "fractional flow reserve," "ifr" or "instantaneous free-wave ratio" as well as additional text words in combination with an established search strategy for MEDLINE/Pubmed. We also hand-searched bibliographies of identified studies, meta-analyses, and coronary revascularization guidelines.
| Selection
Study selection was performed by three independent reviewers (RV, FF, FDA 
| Analysis
Descriptive statistics on baseline and angiographic characteristics of the patients in the studies are provided. Binary variables are reported as median percentages and interquartile range (IQR) and continuous variables as mean and standard deviation (SD).
All endpoints are binary endpoints, and the differences between the groups are measured in terms of odds-ratios (OR).
Network meta-analyses were performed in a Bayesian framework, using a random-effect model accounting for correlations induced by multi-arm trials and with the assumption of homogeneous betweenstudy variance. All the parameters were given minimally informative priors. The posterior distributions of the parameters were obtained with Markov Chain Monte Carlo methods, using two chains. The chains were thinned to reduce autocorrelations, discarding all but every kth sampled value. For each chain, the first 10 000 Monte-Carlo iterations (500 000 in total for death and CV death with a thin of k = 50, and 100 000 in total for the other endpoints with a thin of k = 10) were run to reach convergence and disregarded, then 10 000 further simulations per chain (thinned as before) were run to estimate the parameters.
A risk of bias assessment was performed using the Cochrane risk of bias tool, evaluating the quality of allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), and selective outcome reporting (reporting bias).
The analyses were conducted using R version 3.2.1 (for the direct comparisons, the data manipulations and the results output) and WinBUGS 1.4.3 (for the NMA, run routinely in "batch-mode" from R). propensity score adjusted observational study 22 (see Figure 1 and Supplementary Appendix, web only).
| RESULTS
A total of 4126 patients were evaluated with FFR, 2160 with iFR, and 2214 with CA (see Table 1 Tables S6-S9 ).
Regarding quality of included studies (see appendix web only Table S10 ), all of them were multicenter, with low risk of evaluated bias.
| DISCUSSION
Numerous studies based on myocardial nuclear imaging and stress echocardiography have demonstrated that inducible ischemia is an important prognostic factors among patients with CAD. [23] [24] [25] Moreover, It has already been established that PCI of hemodynamically non-significant stenosis (FFR >0.80) increases the probability of thrombosis and restenosis associated with stent placement, exceeding the low risk associated with the conservative treatment of such lesions. 7, 26 This is why iFR was not directly compared with angiography in the two large RCT that determined its non-inferiority to FFR in driving coronary revascularization. 15, 16 Our analysis showed that functional assessment of stenosis with either FFR or iFR is on the whole safe and effective in reducing the number of PCI compared to CA, curtailing it to functionally significant lesions. This confirms the well-known results of the main trials on FFRguided revascularization, whose patients were followed-up for long periods, demonstrating persistent favorable outcomes with the FFRguided compared to the angiography-guided PCI. 27 Whether the same long-term effect is associated also with iFR-guided revascularization remains to be determined, but since the theoretical assumption at the basis of iFR evaluation share physiology with FFR, 28 a similar safety is expected.
Globally, our results did not evidence any significant differences between FFR and iFR group in the rates of MACE, death, nonfatal MI, and unplanned revascularization at 1 year. On the top of that, our study confirmed that TVR events after 1 year are reduced with the physiology-guided approach compared to the angiography-guided one. TVR represents a failure of the management strategy chosen, so functional approach performs better and deferral of non-significant stenosis appears safe. The fact that no difference at pooled analysis was shown suggests, on a larger scale than in single trials, that the
benefits of a physiologically-guided coronary revascularization with FFR can also be achieved with iFR.
Also, our data showed that patients with stable CAD benefit from the physiologically guided revascularization in terms of risk reduction for subsequent MI. This result stresses the importance of functional evaluation in stable coronary disease patients, in which the mechanism underlying the occurrence of events during follow-up is mainly related to the ischemia-inducing capacity of the lumen reduction.
Either the vasodilatation test of FFR or the instantaneous assessment of iFR (derived from single evaluation or from the evidence of pressure drops during pullback) are able to establish safely which stenosis should be stented and which ones should be deferred. On the other hand, no improvement of that kind has been highlighted in ACS patients. Since the FAME trial, many RCT investigated the role of FFR in the context of ACS: while the low sensitivity of FFR in culprit vessels during ACS has been established, 29, 30 conclusions on its role in assessing non-culprit lesions in ACS are less clear. [30] [31] [32] Generalized transitory micro vascular dysfunction in the peri-infarct period has been suggested as a possible mechanism of the reduced performance of FFR in ACS 33 :
Nonetheless, some authors reported acceptable reliability of FFR performed during the acute phase of ACS in predicting the severity of non-culprit coronary stenosis. FIGURE 2 Network meta-analysis for MACE The wave-free analysis of iFR during diastole does not seem to increase performance against CA, suggesting the major role played by plaque instability characteristics in ACS pathophysiology and the importance of coronary imaging in this setting. The 20% increase in deferred lesion emerged from the DEFINE-FLAIR trial does not seem to affect 1-year outcome. 16 Moreover, the ADVISE II study had concluded that iFR hybrid approach is in agreement with FFR 94% of the time, strengthening iFR even more. 28 It is worth considering that, eliminating the use of adenosine, iFR is cost-saving and ensures a better patient experience, avoiding harmful symptoms like thoracic pain and shortness of breath. Also, it permits evaluation in patients with adenosine contraindications.
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| LIMITATIONS
Our study shares the limitations of its primary sources, namely the short 
CONFLICTS OF INTEREST
We did not receive any funding for this paper. The authors declare no conflict of interest.
ORCID
Roberto Verardi
http://orcid.org/0000-0002-4533-6435
